External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Ophthalmology Retina Society 2024
Roche and Genentech at

Retina Society 2024

September 11 - September 15
Lisbon, Portugal
retinasociety.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
08:59 AM
Duration 5mins PEDRO LEITAO BALLROOM
Port Delivery System With Ranibizumab (PDS) for Continuous Treatment of Diabetic Macular Edema (DME): 2-Year Data From the Phase 3 Pagoda Trial
Regillo C, Awh C, Graff J, Bobbala A, Dakouras A, Howard D, Gune S, Malhotra V, Quezada-Ruiz C, Rabena M
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:00 PM
Duration 5mins PEDRO LEITAO BALLROOM
Technical Updates to the Port Delivery System With Ranibizumab for the Treatment of Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Diabetic Retinopathy
Mittra R, Chang M, Pieramici D, Pearce I, Campochiaro P, Holekamp N, Gune S, Quezada Ruiz C, Singh N, Wise G, Ranade S, Horvath J, Regillo
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:52 AM
Duration 5mins PEDRO LEITAO BALLROOM
Treat-and-Extend Dosing with Faricimab▼ in the Phase 3 BALATON and COMINO Retinal Vein Occlusion Trials: 72-week Results and Real-world Patient Cases
Suner I, Abreu F, Arrisi P, Kotecha A, Liu Y, Paris L, Retiere A, Willis J
Ophthalmology | Retinal Vein Occlusion

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:29 AM
Duration 4mins PEDRO LEITAO BALLROOM
Real-World Effectiveness of Faricimab▼ in Patients With Neovascular Age-Related Macular Degeneration: 12-Month Outcomes From FARETINA-nAMD and FARWIDE-nAMD Studies
Singh R, Tabano D, Ko S, Borkar D, Leng T, Myrick A, Talks J, Peto T, Dayal P, Chi G
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:41 AM
Duration 3mins PEDRO LEITAO BALLROOM
Imaging Biomarkers Supporting the Role of Ang-2 in Dual Inhibition With Faricimab▼ for the Treatment of nAMD and DME
Ali F, Lim J, Singh R, Gibson K, Margaron P, Patel S, Sim D, Yang M
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:53 AM
Duration 3mins PEDRO LEITAO BALLROOM
Response of Large Pigment Epithelial Detachments to Faricimab▼ Versus Aflibercept in Patients With nAMD: A Subgroup Analysis From TENAYA and LUCERNE
Ferrone P, Ambresin A, Avery R, Chaikitmongkol V, Eter N, Gomi F, Khanani A, Lai T, Lim J, London N, Harrell E, Margaron P, Patel S, Souverain A, Yang M
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:56 AM
Duration 3mins PEDRO LEITAO BALLROOM
Association of Early Fluid Resolution With ​Short- and Long-Term Extended Durability in the Head-to-Head Phase of the TENAYA/LUCERNE Trials in Patients With Neovascular Age-Related Macular Degeneration Treated With Faricimab▼
Pitcher J, Gallego-Pinazo R, Amador M, Dagincourt N, Stoilov I, Margaron P
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:59 AM
Duration 3mins PEDRO LEITAO BALLROOM
Analysis of Extended Interval Treatment Outcomes and Potential Q20W Dosing in nAMD With Faricimab▼ from the TENAYA/LUCERNE Trials
Tan C, Ambresin A, Koh A, Patel P, Singer M, Dagincourt N, Hill L, Kotecha A, Margaron P
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
10:23 AM
Duration 5mins PEDRO LEITAO BALLROOM
Port Delivery System With Ranibizumab for Continuous Treatment in Diabetic Retinopathy: First Readout of 2-Year Data From the Phase 3 Pavilion Trial
Awh C, Khanani A, Chang M, Holmes W, Latkany P, Menezes A, Santhanakrishnan A, Tian K, Wetzel-Smith M
Ophthalmology | Diabetic Retinopathy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
10:28 AM
Duration 5mins PEDRO LEITAO BALLROOM
Patient Preference for the Port Delivery System With Ranibizumab (PDS) vs Intravitreal Injections: Results From the Phase 3 Pagoda Trial in Patients With Diabetic Macular Edema (DME)
Marcus D, Chang M, Koh A, Baldonado K, Daly A, Hill L, Poloz Y, Prager A, Menezes A, Tian K
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
10:49 AM
Duration 5mins PEDRO LEITAO BALLROOM
Impact of Early Intraretinal Fluid Reduction (IRF) on One-Year Outcomes in Diabetic Macular Edema (DME)
Sadda, V, Lim J, Wang Y, Hibar D, Maunz A, Lu H, Albrecht T, Gibson K, Willis J, Chang D, Litts K
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
10:54 AM
Duration 5mins PEDRO LEITAO BALLROOM
Real-World Effectiveness of Faricimab▼ in Patients With Diabetic Macular Edema: 12-Month Outcomes From FARETINA-DME and FARWIDE-DME Studies
Borkar D, Tabano D, Ko S, Leng T, Myrick A, Singh R, Talks J, Peto T, Dayal P, Chi G
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:19 AM
Duration 5mins PEDRO LEITAO BALLROOM
Faricimab▼ in DME: Results From the RHONE-X Long-Term Extension Trial
Lai T, Schlottmann P, Khanani A, Kotecha A, Idowu O, Harrell E, Abreu F, Tang Y, Willis J
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:41 AM
Duration 5mins PEDRO LEITAO BALLROOM
Predictors of Extended Treatment Intervals in Patients With Diabetic Macular Edema (DME) Treated With Faricimab▼ in the Phase 3 YOSEMITE/RHINE Trials
Arevalo F, Ambresin A, Gibson K, Sim D, Hill L
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:46 AM
Duration 5mins PEDRO LEITAO BALLROOM
Greater Reduction in Hard Exudates With Faricimab▼ vs Aflibercept in Patients With DME: Biomarker Results From the Phase 3 YOSEMITE/RHINE Trials​
Pollreisz A, Dinah C, Goldberg R, Ip M, Rahimy E, Vujosevic S, Amador M, Gibson K, Glittenberg C, Maunz A, O'Leary O, Uschner D
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:51 AM
Duration 5mins PEDRO LEITAO BALLROOM
Comparison of the Relative Effectiveness of Faricimab▼ vs Aflibercept 8 mg in Diabetic Macular Edema (DME)
Siedlecki J, Leng T, Holekamp N, Mar F, Leng T, Gibson K, Paulo T, Buehrer C, Tabano D
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:47 AM
Duration 5mins PEDRO LEITAO BALLROOM
The Clinical Impact of Continuous Delivery of Ranibizumab With the Port Delivery System (PDS) in Neovascular Age-Related Macular Degeneration (nAMD) in Portal and Archway
Rachitskaya A, Holekamp N, Dauletbekov D, Blotner S, Heinrich D
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.